| Literature DB >> 25806574 |
Christy E Newman1, Limin Mao, Asha Persson, Martin Holt, Sean Slavin, Michael R Kidd, Jeffrey J Post, Edwina Wright, John de Wit.
Abstract
Current debates regarding the use of antiretroviral therapy (ART) to promote both individual- and population-level health benefits underscore the importance of understanding why a subpopulation of people with diagnosed HIV and access to treatment choose not to use it. Semi-structured interviews were conducted between 2012 and 2014 with 27 people living with HIV in Australia who were not using ART at the time of interview. Analytic triangulation permitted an appreciation of not only the varied personal reasons for non-use of treatment, but also underlying views on HIV treatment, and the ideal conditions imagined necessary for treatment initiation. Policy goals to increase the number of people with HIV using ART must recognize the diverse explanations for non-use of ART, which include concerns about the various impacts of committing to lifelong pharmaceutical treatment use. Our research identified distinctive subgroups among people who are not using antiretroviral therapy, with a range of individual and social needs that may affect treatment decisions. These findings challenge assumptions about treatment non-use in resource-rich settings, revealing persistent consumer fears about the potent and unknown effects of HIV medications that deserve greater recognition in policy debate on treatment uptake.Entities:
Mesh:
Year: 2015 PMID: 25806574 PMCID: PMC4410544 DOI: 10.1089/apc.2014.0301
Source DB: PubMed Journal: AIDS Patient Care STDS ISSN: 1087-2914 Impact factor: 5.078